caffeic acid phenethyl ester has been researched along with Acute Lung Injury in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Chen, H; Chen, L; Chen, P; Fu, W; Jin, Y; Liang, G; Liu, Z; Lu, M; Song, Z; Sun, C; Wang, Y; Zhang, Y; Zheng, L | 1 |
1 other study(ies) available for caffeic acid phenethyl ester and Acute Lung Injury
| Article | Year |
|---|---|
Discovery of caffeic acid phenethyl ester derivatives as novel myeloid differentiation protein 2 inhibitors for treatment of acute lung injury.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caffeic Acids; Cytokines; Dose-Response Relationship, Drug; Drug Discovery; Humans; Inflammation; Lipopolysaccharides; Lymphocyte Antigen 96; Macrophages; Mice; Mice, Inbred C57BL; Molecular Structure; Phenylethyl Alcohol; Structure-Activity Relationship | 2018 |